Locations
Conditions
Treatments
Institutions
Resources
For researchers
About us
Clinical trials
The Use of Cytomegalovirus Cell Mediated Immunity to Optimize the Duration of Letermovir Prophylaxis in Hematopoietic Cell Transplant Recipients
Apply
Leterovir
The Use of Cytomegalovirus Cell Mediated Immunity to Optimize the Duration of Letermovir Prophylaxis in Hematopoietic Cell Transplant Recipients
Basic information
Step 1/5
Provide your basic information
Age
ZIP code
Back
Next step